Surgepays is trading at $0.14, up 10.70%, with no confirmed company-specific announcement explaining the move.
- Its latest reported company news was the GrowthLine partner-brand launch on October 15.
- U.S. stocks moved higher as investors looked ahead to major earnings reports and the Federal Reserve decision, but available reporting does not establish that this market backdrop caused Surgepays’ gain.